context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
During the years ended December 31, 2024, 2023, and 2022, interest expense (income) and penalties recorded in the consolidated statements of operations were $ 0.03 million, $ 0.02 million, and $( 0.02 ) million, respectively. Following is a reconciliation of the amounts of unrecognized tax benefits, net of tax and excluding interest and penalties, for the years ended December 31, 2024, 2023, and 2022 (in thousands): | text | 0.03 | monetaryItemType | text: <entity> 0.03 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, interest expense (income) and penalties recorded in the consolidated statements of operations were $ 0.03 million, $ 0.02 million, and $( 0.02 ) million, respectively. Following is a reconciliation of the amounts of unrecognized tax benefits, net of tax and excluding interest and penalties, for the years ended December 31, 2024, 2023, and 2022 (in thousands): </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
During the years ended December 31, 2024, 2023, and 2022, interest expense (income) and penalties recorded in the consolidated statements of operations were $ 0.03 million, $ 0.02 million, and $( 0.02 ) million, respectively. Following is a reconciliation of the amounts of unrecognized tax benefits, net of tax and excluding interest and penalties, for the years ended December 31, 2024, 2023, and 2022 (in thousands): | text | 0.02 | monetaryItemType | text: <entity> 0.02 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, interest expense (income) and penalties recorded in the consolidated statements of operations were $ 0.03 million, $ 0.02 million, and $( 0.02 ) million, respectively. Following is a reconciliation of the amounts of unrecognized tax benefits, net of tax and excluding interest and penalties, for the years ended December 31, 2024, 2023, and 2022 (in thousands): </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
The foregoing table indicates unrecognized tax benefits, net of tax and excluding interest and penalties. The balance of gross unrecognized benefits was $ 1.0 million, $ 1.0 million, and $ 0.8 million at December 31, 2024, 2023, and 2022, respectively. If the unrecognized tax benefits at December 31, 2024, 2023, and 2022 were recognized in full, tax benefits of $ 1.0 million, $ 1.0 million, and $ 0.8 million, respectively, would affect the effective tax rate. | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> The foregoing table indicates unrecognized tax benefits, net of tax and excluding interest and penalties. The balance of gross unrecognized benefits was $ 1.0 million, $ 1.0 million, and $ 0.8 million at December 31, 2024, 2023, and 2022, respectively. If the unrecognized tax benefits at December 31, 2024, 2023, and 2022 were recognized in full, tax benefits of $ 1.0 million, $ 1.0 million, and $ 0.8 million, respectively, would affect the effective tax rate. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The foregoing table indicates unrecognized tax benefits, net of tax and excluding interest and penalties. The balance of gross unrecognized benefits was $ 1.0 million, $ 1.0 million, and $ 0.8 million at December 31, 2024, 2023, and 2022, respectively. If the unrecognized tax benefits at December 31, 2024, 2023, and 2022 were recognized in full, tax benefits of $ 1.0 million, $ 1.0 million, and $ 0.8 million, respectively, would affect the effective tax rate. | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> The foregoing table indicates unrecognized tax benefits, net of tax and excluding interest and penalties. The balance of gross unrecognized benefits was $ 1.0 million, $ 1.0 million, and $ 0.8 million at December 31, 2024, 2023, and 2022, respectively. If the unrecognized tax benefits at December 31, 2024, 2023, and 2022 were recognized in full, tax benefits of $ 1.0 million, $ 1.0 million, and $ 0.8 million, respectively, would affect the effective tax rate. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company has a savings plan (the “Savings Plan”) that qualifies as a deferred salary arrangement under Section 401(k) of the Code. Under the Savings Plan, participating employees may defer a portion of their pretax earnings, up to the Internal Revenue Service annual contribution limit. The Company contributed $ 2.2 million, $ 2.4 million, and $ 2.1 million for the years ended December 31, 2024, 2023 and 2022, respectively, to match employee contributions to the Savings Plan. | text | 2.2 | monetaryItemType | text: <entity> 2.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a savings plan (the “Savings Plan”) that qualifies as a deferred salary arrangement under Section 401(k) of the Code. Under the Savings Plan, participating employees may defer a portion of their pretax earnings, up to the Internal Revenue Service annual contribution limit. The Company contributed $ 2.2 million, $ 2.4 million, and $ 2.1 million for the years ended December 31, 2024, 2023 and 2022, respectively, to match employee contributions to the Savings Plan. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
The Company has a savings plan (the “Savings Plan”) that qualifies as a deferred salary arrangement under Section 401(k) of the Code. Under the Savings Plan, participating employees may defer a portion of their pretax earnings, up to the Internal Revenue Service annual contribution limit. The Company contributed $ 2.2 million, $ 2.4 million, and $ 2.1 million for the years ended December 31, 2024, 2023 and 2022, respectively, to match employee contributions to the Savings Plan. | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a savings plan (the “Savings Plan”) that qualifies as a deferred salary arrangement under Section 401(k) of the Code. Under the Savings Plan, participating employees may defer a portion of their pretax earnings, up to the Internal Revenue Service annual contribution limit. The Company contributed $ 2.2 million, $ 2.4 million, and $ 2.1 million for the years ended December 31, 2024, 2023 and 2022, respectively, to match employee contributions to the Savings Plan. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
The Company has a savings plan (the “Savings Plan”) that qualifies as a deferred salary arrangement under Section 401(k) of the Code. Under the Savings Plan, participating employees may defer a portion of their pretax earnings, up to the Internal Revenue Service annual contribution limit. The Company contributed $ 2.2 million, $ 2.4 million, and $ 2.1 million for the years ended December 31, 2024, 2023 and 2022, respectively, to match employee contributions to the Savings Plan. | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a savings plan (the “Savings Plan”) that qualifies as a deferred salary arrangement under Section 401(k) of the Code. Under the Savings Plan, participating employees may defer a portion of their pretax earnings, up to the Internal Revenue Service annual contribution limit. The Company contributed $ 2.2 million, $ 2.4 million, and $ 2.1 million for the years ended December 31, 2024, 2023 and 2022, respectively, to match employee contributions to the Savings Plan. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
Advertising costs are expensed as incurred. These costs totaled $ 28 million, $ 31 million and $ 33 million for the years ended 2024, 2023 and 2022, respectively. | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred. These costs totaled $ 28 million, $ 31 million and $ 33 million for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
Advertising costs are expensed as incurred. These costs totaled $ 28 million, $ 31 million and $ 33 million for the years ended 2024, 2023 and 2022, respectively. | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred. These costs totaled $ 28 million, $ 31 million and $ 33 million for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
Advertising costs are expensed as incurred. These costs totaled $ 28 million, $ 31 million and $ 33 million for the years ended 2024, 2023 and 2022, respectively. | text | 33 | monetaryItemType | text: <entity> 33 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred. These costs totaled $ 28 million, $ 31 million and $ 33 million for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
The Company’s remaining performance obligations relate to services and software solutions. The aggregated transaction price allocated to remaining performance obligations for arrangements with an original term exceeding one year was $ 1.19 billion and $ 1.13 billion, inclusive of deferred revenue, as of December 31, 2024 and 2023, respectively. On average, remaining performance obligations as of December 31, 2024 and 2023 are expected to be recognized over a period of approximately two years . | text | 1.19 | monetaryItemType | text: <entity> 1.19 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s remaining performance obligations relate to services and software solutions. The aggregated transaction price allocated to remaining performance obligations for arrangements with an original term exceeding one year was $ 1.19 billion and $ 1.13 billion, inclusive of deferred revenue, as of December 31, 2024 and 2023, respectively. On average, remaining performance obligations as of December 31, 2024 and 2023 are expected to be recognized over a period of approximately two years . </context> | us-gaap:RevenueRemainingPerformanceObligation |
The Company’s remaining performance obligations relate to services and software solutions. The aggregated transaction price allocated to remaining performance obligations for arrangements with an original term exceeding one year was $ 1.19 billion and $ 1.13 billion, inclusive of deferred revenue, as of December 31, 2024 and 2023, respectively. On average, remaining performance obligations as of December 31, 2024 and 2023 are expected to be recognized over a period of approximately two years . | text | 1.13 | monetaryItemType | text: <entity> 1.13 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s remaining performance obligations relate to services and software solutions. The aggregated transaction price allocated to remaining performance obligations for arrangements with an original term exceeding one year was $ 1.19 billion and $ 1.13 billion, inclusive of deferred revenue, as of December 31, 2024 and 2023, respectively. On average, remaining performance obligations as of December 31, 2024 and 2023 are expected to be recognized over a period of approximately two years . </context> | us-gaap:RevenueRemainingPerformanceObligation |
Progress on satisfying performance obligations under contracts with customers related to billed revenues is reflected on the Consolidated Balance Sheets in Accounts receivable, net. Progress on satisfying performance obligations under contracts with customers related to unbilled revenues (“contract assets”) is reflected on the Consolidated Balance Sheets as Prepaid expenses and other current assets for revenues expected to be billed within the next twelve months, and Other long-term assets for revenues expected to be billed thereafter. The total contract asset balances were $ 11 million and $ 16 million as of December 31, 2024 and 2023, respectively. These contract assets result from timing differences between billing and satisfying performance obligations, as well as the impact from the allocation of the transaction price among performance obligations for contracts that include multiple performance obligations. Contract assets are evaluated for impairment and no impairment losses have been recognized during the years ended December 31, 2024, 2023 and 2022, respectively. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> Progress on satisfying performance obligations under contracts with customers related to billed revenues is reflected on the Consolidated Balance Sheets in Accounts receivable, net. Progress on satisfying performance obligations under contracts with customers related to unbilled revenues (“contract assets”) is reflected on the Consolidated Balance Sheets as Prepaid expenses and other current assets for revenues expected to be billed within the next twelve months, and Other long-term assets for revenues expected to be billed thereafter. The total contract asset balances were $ 11 million and $ 16 million as of December 31, 2024 and 2023, respectively. These contract assets result from timing differences between billing and satisfying performance obligations, as well as the impact from the allocation of the transaction price among performance obligations for contracts that include multiple performance obligations. Contract assets are evaluated for impairment and no impairment losses have been recognized during the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerAssetNetCurrent |
Progress on satisfying performance obligations under contracts with customers related to billed revenues is reflected on the Consolidated Balance Sheets in Accounts receivable, net. Progress on satisfying performance obligations under contracts with customers related to unbilled revenues (“contract assets”) is reflected on the Consolidated Balance Sheets as Prepaid expenses and other current assets for revenues expected to be billed within the next twelve months, and Other long-term assets for revenues expected to be billed thereafter. The total contract asset balances were $ 11 million and $ 16 million as of December 31, 2024 and 2023, respectively. These contract assets result from timing differences between billing and satisfying performance obligations, as well as the impact from the allocation of the transaction price among performance obligations for contracts that include multiple performance obligations. Contract assets are evaluated for impairment and no impairment losses have been recognized during the years ended December 31, 2024, 2023 and 2022, respectively. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> Progress on satisfying performance obligations under contracts with customers related to billed revenues is reflected on the Consolidated Balance Sheets in Accounts receivable, net. Progress on satisfying performance obligations under contracts with customers related to unbilled revenues (“contract assets”) is reflected on the Consolidated Balance Sheets as Prepaid expenses and other current assets for revenues expected to be billed within the next twelve months, and Other long-term assets for revenues expected to be billed thereafter. The total contract asset balances were $ 11 million and $ 16 million as of December 31, 2024 and 2023, respectively. These contract assets result from timing differences between billing and satisfying performance obligations, as well as the impact from the allocation of the transaction price among performance obligations for contracts that include multiple performance obligations. Contract assets are evaluated for impairment and no impairment losses have been recognized during the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerAssetNetCurrent |
Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. | text | 757 | monetaryItemType | text: <entity> 757 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerLiability |
Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. | text | 770 | monetaryItemType | text: <entity> 770 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerLiability |
Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. | text | 455 | monetaryItemType | text: <entity> 455 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. | text | 432 | monetaryItemType | text: <entity> 432 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. | text | 399 | monetaryItemType | text: <entity> 399 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $ 757 million and $ 770 million as of December 31, 2024 and 2023, respectively. The Company recognized $ 455 million, $ 432 million and $ 399 million in revenue that was previously included in the beginning balance of deferred revenue during the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
The acquisition was accounted for under the acquisition method of accounting for business combinations. The Company’s final purchase consideration was $ 881 million comprised of cash paid, net of Matrox’s cash on-hand. | text | 881 | monetaryItemType | text: <entity> 881 </entity> <entity type> monetaryItemType </entity type> <context> The acquisition was accounted for under the acquisition method of accounting for business combinations. The Company’s final purchase consideration was $ 881 million comprised of cash paid, net of Matrox’s cash on-hand. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
The $ 639 million of goodwill, which is non-deductible for tax purposes, has been allocated to the EVM segment and principally relates to the planned global expansion and integration of Matrox into the Company’s machine vision offerings. | text | 639 | monetaryItemType | text: <entity> 639 </entity> <entity type> monetaryItemType </entity type> <context> The $ 639 million of goodwill, which is non-deductible for tax purposes, has been allocated to the EVM segment and principally relates to the planned global expansion and integration of Matrox into the Company’s machine vision offerings. </context> | us-gaap:Goodwill |
The Company incurred $ 6 million, $ 6 million and $ 21 million of acquisition-related costs during the years ended December 31, 2024, 2023 and 2022 | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurred $ 6 million, $ 6 million and $ 21 million of acquisition-related costs during the years ended December 31, 2024, 2023 and 2022 </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
The Company incurred $ 6 million, $ 6 million and $ 21 million of acquisition-related costs during the years ended December 31, 2024, 2023 and 2022 | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurred $ 6 million, $ 6 million and $ 21 million of acquisition-related costs during the years ended December 31, 2024, 2023 and 2022 </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
The Company’s goodwill balance consists of four reporting units. The Company completed its annual goodwill impairment testing during the fourth quarter of 2024 utilizing a quantitative approach. The estimated fair value of each reporting unit exceeded its carrying value by at least 150 %. No events occurred during the fiscal years ended 2024, 2023 or 2022 that indicated it was more likely than not that our goodwill was impaired. | text | four | integerItemType | text: <entity> four </entity> <entity type> integerItemType </entity type> <context> The Company’s goodwill balance consists of four reporting units. The Company completed its annual goodwill impairment testing during the fourth quarter of 2024 utilizing a quantitative approach. The estimated fair value of each reporting unit exceeded its carrying value by at least 150 %. No events occurred during the fiscal years ended 2024, 2023 or 2022 that indicated it was more likely than not that our goodwill was impaired. </context> | us-gaap:NumberOfReportingUnits |
The Company’s goodwill balance consists of four reporting units. The Company completed its annual goodwill impairment testing during the fourth quarter of 2024 utilizing a quantitative approach. The estimated fair value of each reporting unit exceeded its carrying value by at least 150 %. No events occurred during the fiscal years ended 2024, 2023 or 2022 that indicated it was more likely than not that our goodwill was impaired. | text | 150 | percentItemType | text: <entity> 150 </entity> <entity type> percentItemType </entity type> <context> The Company’s goodwill balance consists of four reporting units. The Company completed its annual goodwill impairment testing during the fourth quarter of 2024 utilizing a quantitative approach. The estimated fair value of each reporting unit exceeded its carrying value by at least 150 %. No events occurred during the fiscal years ended 2024, 2023 or 2022 that indicated it was more likely than not that our goodwill was impaired. </context> | us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount |
Amortization expense was $ 104 million, $ 104 million and $ 136 million for fiscal years ended 2024, 2023 and 2022, respectively. | text | 104 | monetaryItemType | text: <entity> 104 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense was $ 104 million, $ 104 million and $ 136 million for fiscal years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense was $ 104 million, $ 104 million and $ 136 million for fiscal years ended 2024, 2023 and 2022, respectively. | text | 136 | monetaryItemType | text: <entity> 136 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense was $ 104 million, $ 104 million and $ 136 million for fiscal years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Depreciation expense was $ 68 million, $ 72 million and $ 68 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 68 | monetaryItemType | text: <entity> 68 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense was $ 68 million, $ 72 million and $ 68 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:Depreciation |
Depreciation expense was $ 68 million, $ 72 million and $ 68 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 72 | monetaryItemType | text: <entity> 72 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense was $ 68 million, $ 72 million and $ 68 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:Depreciation |
Total charges associated with the 2022 Productivity Plan, which was completed in the third quarter of 2024, and the U.S. voluntary retirement plan, which was completed in 2023, were $ 127 million, including $ 17 million, $ 98 million and $ 12 million for the years ended December 31, 2024, 2023 and 2022 respectively. | text | 127 | monetaryItemType | text: <entity> 127 </entity> <entity type> monetaryItemType </entity type> <context> Total charges associated with the 2022 Productivity Plan, which was completed in the third quarter of 2024, and the U.S. voluntary retirement plan, which was completed in 2023, were $ 127 million, including $ 17 million, $ 98 million and $ 12 million for the years ended December 31, 2024, 2023 and 2022 respectively. </context> | us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 |
Total charges associated with the 2022 Productivity Plan, which was completed in the third quarter of 2024, and the U.S. voluntary retirement plan, which was completed in 2023, were $ 127 million, including $ 17 million, $ 98 million and $ 12 million for the years ended December 31, 2024, 2023 and 2022 respectively. | text | 17 | monetaryItemType | text: <entity> 17 </entity> <entity type> monetaryItemType </entity type> <context> Total charges associated with the 2022 Productivity Plan, which was completed in the third quarter of 2024, and the U.S. voluntary retirement plan, which was completed in 2023, were $ 127 million, including $ 17 million, $ 98 million and $ 12 million for the years ended December 31, 2024, 2023 and 2022 respectively. </context> | us-gaap:RestructuringCharges |
Total charges associated with the 2022 Productivity Plan, which was completed in the third quarter of 2024, and the U.S. voluntary retirement plan, which was completed in 2023, were $ 127 million, including $ 17 million, $ 98 million and $ 12 million for the years ended December 31, 2024, 2023 and 2022 respectively. | text | 98 | monetaryItemType | text: <entity> 98 </entity> <entity type> monetaryItemType </entity type> <context> Total charges associated with the 2022 Productivity Plan, which was completed in the third quarter of 2024, and the U.S. voluntary retirement plan, which was completed in 2023, were $ 127 million, including $ 17 million, $ 98 million and $ 12 million for the years ended December 31, 2024, 2023 and 2022 respectively. </context> | us-gaap:RestructuringCharges |
Total charges associated with the 2022 Productivity Plan, which was completed in the third quarter of 2024, and the U.S. voluntary retirement plan, which was completed in 2023, were $ 127 million, including $ 17 million, $ 98 million and $ 12 million for the years ended December 31, 2024, 2023 and 2022 respectively. | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> Total charges associated with the 2022 Productivity Plan, which was completed in the third quarter of 2024, and the U.S. voluntary retirement plan, which was completed in 2023, were $ 127 million, including $ 17 million, $ 98 million and $ 12 million for the years ended December 31, 2024, 2023 and 2022 respectively. </context> | us-gaap:RestructuringCharges |
The costs of these plans are classified within Exit and restructuring on the Consolidated Statements of Operations. The Company’s remaining payment obligations of $ 4 million, are reflected within Accrued liabilities on the Consolidated Balance Sheets. | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> The costs of these plans are classified within Exit and restructuring on the Consolidated Statements of Operations. The Company’s remaining payment obligations of $ 4 million, are reflected within Accrued liabilities on the Consolidated Balance Sheets. </context> | us-gaap:RestructuringReserve |
The Company incurred Exit and restructuring costs, under previously announced programs of $ 2 million for the year ended December 31, 2022. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurred Exit and restructuring costs, under previously announced programs of $ 2 million for the year ended December 31, 2022. </context> | us-gaap:RestructuringCharges |
The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. </context> | us-gaap:DerivativeGainLossOnDerivativeNet |
The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. </context> | us-gaap:DerivativeGainLossOnDerivativeNet |
The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. | text | 87 | monetaryItemType | text: <entity> 87 </entity> <entity type> monetaryItemType </entity type> <context> The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. </context> | us-gaap:DerivativeGainLossOnDerivativeNet |
The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. | text | 592 | monetaryItemType | text: <entity> 592 </entity> <entity type> monetaryItemType </entity type> <context> The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. </context> | us-gaap:DerivativeNotionalAmount |
The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. | text | 485 | monetaryItemType | text: <entity> 485 </entity> <entity type> monetaryItemType </entity type> <context> The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $ 11 million of gains for the year ended December 31, 2024, $ 15 million of losses for the year ended December 31, 2023 and $ 87 million of gains for the year ended December 31, 2022. As of December 31, 2024 and 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were € 592 million and € 485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective. </context> | us-gaap:DerivativeNotionalAmount |
The principal on Term Loan A is due in quarterly installments, with the next quarterly installment due in the second quarter of 2026 and the majority due upon maturity in 2027. The Company has and may make prepayments in whole or in part, without premium or penalty; and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. As of December 31, 2024, the Term Loan A interest rate was 5.71 %. Interest payments are made monthly and are subject to variable rates plus an applicable margin. | text | 5.71 | percentItemType | text: <entity> 5.71 </entity> <entity type> percentItemType </entity type> <context> The principal on Term Loan A is due in quarterly installments, with the next quarterly installment due in the second quarter of 2026 and the majority due upon maturity in 2027. The Company has and may make prepayments in whole or in part, without premium or penalty; and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. As of December 31, 2024, the Term Loan A interest rate was 5.71 %. Interest payments are made monthly and are subject to variable rates plus an applicable margin. </context> | us-gaap:LongTermDebtPercentageBearingVariableInterestRate |
In the second quarter of 2024, the Company completed a private offering of $ 500 million senior unsecured notes (the “Senior Notes”) with a 6.5 % fixed interest rate. The net proceeds of the issuance, after deducting debt issuance costs which were deferred, were approximately $ 492 million. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year, commencing on December 1, 2024. The Company may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> In the second quarter of 2024, the Company completed a private offering of $ 500 million senior unsecured notes (the “Senior Notes”) with a 6.5 % fixed interest rate. The net proceeds of the issuance, after deducting debt issuance costs which were deferred, were approximately $ 492 million. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year, commencing on December 1, 2024. The Company may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. </context> | us-gaap:DebtInstrumentFaceAmount |
In the second quarter of 2024, the Company completed a private offering of $ 500 million senior unsecured notes (the “Senior Notes”) with a 6.5 % fixed interest rate. The net proceeds of the issuance, after deducting debt issuance costs which were deferred, were approximately $ 492 million. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year, commencing on December 1, 2024. The Company may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. | text | 6.5 | percentItemType | text: <entity> 6.5 </entity> <entity type> percentItemType </entity type> <context> In the second quarter of 2024, the Company completed a private offering of $ 500 million senior unsecured notes (the “Senior Notes”) with a 6.5 % fixed interest rate. The net proceeds of the issuance, after deducting debt issuance costs which were deferred, were approximately $ 492 million. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year, commencing on December 1, 2024. The Company may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In the second quarter of 2024, the Company completed a private offering of $ 500 million senior unsecured notes (the “Senior Notes”) with a 6.5 % fixed interest rate. The net proceeds of the issuance, after deducting debt issuance costs which were deferred, were approximately $ 492 million. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year, commencing on December 1, 2024. The Company may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. | text | 492 | monetaryItemType | text: <entity> 492 </entity> <entity type> monetaryItemType </entity type> <context> In the second quarter of 2024, the Company completed a private offering of $ 500 million senior unsecured notes (the “Senior Notes”) with a 6.5 % fixed interest rate. The net proceeds of the issuance, after deducting debt issuance costs which were deferred, were approximately $ 492 million. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year, commencing on December 1, 2024. The Company may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. </context> | us-gaap:ProceedsFromIssuanceOfLongTermDebt |
The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of December 31, 2024, the Company had letters of credit totaling $ 10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $ 1,500 million to $ 1,490 million. As of December 31, 2024, the Revolving Credit Facility had an average interest rate of 5.68 %. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of December 31, 2024, the Company had letters of credit totaling $ 10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $ 1,500 million to $ 1,490 million. As of December 31, 2024, the Revolving Credit Facility had an average interest rate of 5.68 %. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027. </context> | us-gaap:LettersOfCreditOutstandingAmount |
The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of December 31, 2024, the Company had letters of credit totaling $ 10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $ 1,500 million to $ 1,490 million. As of December 31, 2024, the Revolving Credit Facility had an average interest rate of 5.68 %. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027. | text | 1500 | monetaryItemType | text: <entity> 1500 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of December 31, 2024, the Company had letters of credit totaling $ 10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $ 1,500 million to $ 1,490 million. As of December 31, 2024, the Revolving Credit Facility had an average interest rate of 5.68 %. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of December 31, 2024, the Company had letters of credit totaling $ 10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $ 1,500 million to $ 1,490 million. As of December 31, 2024, the Revolving Credit Facility had an average interest rate of 5.68 %. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027. | text | 1490 | monetaryItemType | text: <entity> 1490 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of December 31, 2024, the Company had letters of credit totaling $ 10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $ 1,500 million to $ 1,490 million. As of December 31, 2024, the Revolving Credit Facility had an average interest rate of 5.68 %. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027. </context> | us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity |
The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of December 31, 2024, the Company had letters of credit totaling $ 10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $ 1,500 million to $ 1,490 million. As of December 31, 2024, the Revolving Credit Facility had an average interest rate of 5.68 %. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027. | text | 5.68 | percentItemType | text: <entity> 5.68 </entity> <entity type> percentItemType </entity type> <context> The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of December 31, 2024, the Company had letters of credit totaling $ 10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $ 1,500 million to $ 1,490 million. As of December 31, 2024, the Revolving Credit Facility had an average interest rate of 5.68 %. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027. </context> | us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd |
As of December 31, 2024, the Company has a Receivables Financing Facility with a borrowing limit of up to $ 180 million. As collateral, the Company pledges perfected first-priority security interests in its U.S. domestically originated accounts receivable. The Company has accounted for transactions under this facility as secured borrowings. During the first quarter of 2024, the Company amended this facility to extend the maturity to March 19, 2027 but otherwise did not substantially change the terms of the facility. | text | 180 | monetaryItemType | text: <entity> 180 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company has a Receivables Financing Facility with a borrowing limit of up to $ 180 million. As collateral, the Company pledges perfected first-priority security interests in its U.S. domestically originated accounts receivable. The Company has accounted for transactions under this facility as secured borrowings. During the first quarter of 2024, the Company amended this facility to extend the maturity to March 19, 2027 but otherwise did not substantially change the terms of the facility. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
As of December 31, 2024, the Company’s Consolidated Balance Sheets included $ 638 million of gross receivables that were pledged under the facility. As of December 31, 2024, $ 108 million had been borrowed, of which $ 79 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of December 31, 2024, the facility had an average interest rate of 5.38 %. Interest is paid monthly on these borrowings. | text | 638 | monetaryItemType | text: <entity> 638 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company’s Consolidated Balance Sheets included $ 638 million of gross receivables that were pledged under the facility. As of December 31, 2024, $ 108 million had been borrowed, of which $ 79 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of December 31, 2024, the facility had an average interest rate of 5.38 %. Interest is paid monthly on these borrowings. </context> | us-gaap:AccountsReceivableFromSecuritization |
As of December 31, 2024, the Company’s Consolidated Balance Sheets included $ 638 million of gross receivables that were pledged under the facility. As of December 31, 2024, $ 108 million had been borrowed, of which $ 79 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of December 31, 2024, the facility had an average interest rate of 5.38 %. Interest is paid monthly on these borrowings. | text | 108 | monetaryItemType | text: <entity> 108 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company’s Consolidated Balance Sheets included $ 638 million of gross receivables that were pledged under the facility. As of December 31, 2024, $ 108 million had been borrowed, of which $ 79 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of December 31, 2024, the facility had an average interest rate of 5.38 %. Interest is paid monthly on these borrowings. </context> | us-gaap:LineOfCredit |
As of December 31, 2024, the Company’s Consolidated Balance Sheets included $ 638 million of gross receivables that were pledged under the facility. As of December 31, 2024, $ 108 million had been borrowed, of which $ 79 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of December 31, 2024, the facility had an average interest rate of 5.38 %. Interest is paid monthly on these borrowings. | text | 79 | monetaryItemType | text: <entity> 79 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company’s Consolidated Balance Sheets included $ 638 million of gross receivables that were pledged under the facility. As of December 31, 2024, $ 108 million had been borrowed, of which $ 79 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of December 31, 2024, the facility had an average interest rate of 5.38 %. Interest is paid monthly on these borrowings. </context> | us-gaap:LinesOfCreditCurrent |
As of December 31, 2024, the Company’s Consolidated Balance Sheets included $ 638 million of gross receivables that were pledged under the facility. As of December 31, 2024, $ 108 million had been borrowed, of which $ 79 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of December 31, 2024, the facility had an average interest rate of 5.38 %. Interest is paid monthly on these borrowings. | text | 5.38 | percentItemType | text: <entity> 5.38 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, the Company’s Consolidated Balance Sheets included $ 638 million of gross receivables that were pledged under the facility. As of December 31, 2024, $ 108 million had been borrowed, of which $ 79 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of December 31, 2024, the facility had an average interest rate of 5.38 %. Interest is paid monthly on these borrowings. </context> | us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd |
The weighted average remaining term of the Company’s leases was approximately 6 years each as of December 31, 2024, 2023 and 2022. The weighted average discount rate used to measure the ROU assets and lease liabilities was approximately 6 % as of both December 31, 2024 and December 31, 2023, respectively, and 5 % as of December 31, 2022. | text | 5 | percentItemType | text: <entity> 5 </entity> <entity type> percentItemType </entity type> <context> The weighted average remaining term of the Company’s leases was approximately 6 years each as of December 31, 2024, 2023 and 2022. The weighted average discount rate used to measure the ROU assets and lease liabilities was approximately 6 % as of both December 31, 2024 and December 31, 2023, respectively, and 5 % as of December 31, 2022. </context> | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
We record a liability for non-cancellable purchase commitments for quantities in excess of our forecasted demand consistent with the assessment of net realizable value of our inventory, which is included within Current liabilities on the Consolidated Balance Sheets. There was no liability for these purchase commitments as of December 31, 2024 and an $ 11 million liability as of December 31, 2023. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> We record a liability for non-cancellable purchase commitments for quantities in excess of our forecasted demand consistent with the assessment of net realizable value of our inventory, which is included within Current liabilities on the Consolidated Balance Sheets. There was no liability for these purchase commitments as of December 31, 2024 and an $ 11 million liability as of December 31, 2023. </context> | us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted |
We record a liability for non-cancellable purchase commitments for quantities in excess of our forecasted demand consistent with the assessment of net realizable value of our inventory, which is included within Current liabilities on the Consolidated Balance Sheets. There was no liability for these purchase commitments as of December 31, 2024 and an $ 11 million liability as of December 31, 2023. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> We record a liability for non-cancellable purchase commitments for quantities in excess of our forecasted demand consistent with the assessment of net realizable value of our inventory, which is included within Current liabilities on the Consolidated Balance Sheets. There was no liability for these purchase commitments as of December 31, 2024 and an $ 11 million liability as of December 31, 2023. </context> | us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted |
The Company uses treasury shares as its source for issuing shares under the share-based compensation programs. As of December 31, 2024, the Company had 1,841,117 shares of Class A Common Stock remaining available to be issued under the 2018 Plan. | text | 1841117 | sharesItemType | text: <entity> 1841117 </entity> <entity type> sharesItemType </entity type> <context> The Company uses treasury shares as its source for issuing shares under the share-based compensation programs. As of December 31, 2024, the Company had 1,841,117 shares of Class A Common Stock remaining available to be issued under the 2018 Plan. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
As of December 31, 2024, total unearned compensation cost related to the Company’s share-based compensation plans was $ 127 million, which will be recognized over the weighted average remaining service period of approximately 1.4 years. | text | 127 | monetaryItemType | text: <entity> 127 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, total unearned compensation cost related to the Company’s share-based compensation plans was $ 127 million, which will be recognized over the weighted average remaining service period of approximately 1.4 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
The Company issues RSAs to non-employee directors. The number of shares granted to each non-employee director is determined by dividing the value of the annual grant by the price of a share of the Company’s Class A Common Stock. New directors in any fiscal year earn a prorated amount. During fiscal 2024, there were 6,264 shares granted to non-employee directors compared to 6,640 and 5,686 during fiscal 2023 and 2022, respectively. The shares vest immediately upon grant. | text | 6264 | sharesItemType | text: <entity> 6264 </entity> <entity type> sharesItemType </entity type> <context> The Company issues RSAs to non-employee directors. The number of shares granted to each non-employee director is determined by dividing the value of the annual grant by the price of a share of the Company’s Class A Common Stock. New directors in any fiscal year earn a prorated amount. During fiscal 2024, there were 6,264 shares granted to non-employee directors compared to 6,640 and 5,686 during fiscal 2023 and 2022, respectively. The shares vest immediately upon grant. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The Company issues RSAs to non-employee directors. The number of shares granted to each non-employee director is determined by dividing the value of the annual grant by the price of a share of the Company’s Class A Common Stock. New directors in any fiscal year earn a prorated amount. During fiscal 2024, there were 6,264 shares granted to non-employee directors compared to 6,640 and 5,686 during fiscal 2023 and 2022, respectively. The shares vest immediately upon grant. | text | 6640 | sharesItemType | text: <entity> 6640 </entity> <entity type> sharesItemType </entity type> <context> The Company issues RSAs to non-employee directors. The number of shares granted to each non-employee director is determined by dividing the value of the annual grant by the price of a share of the Company’s Class A Common Stock. New directors in any fiscal year earn a prorated amount. During fiscal 2024, there were 6,264 shares granted to non-employee directors compared to 6,640 and 5,686 during fiscal 2023 and 2022, respectively. The shares vest immediately upon grant. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The Company issues RSAs to non-employee directors. The number of shares granted to each non-employee director is determined by dividing the value of the annual grant by the price of a share of the Company’s Class A Common Stock. New directors in any fiscal year earn a prorated amount. During fiscal 2024, there were 6,264 shares granted to non-employee directors compared to 6,640 and 5,686 during fiscal 2023 and 2022, respectively. The shares vest immediately upon grant. | text | 5686 | sharesItemType | text: <entity> 5686 </entity> <entity type> sharesItemType </entity type> <context> The Company issues RSAs to non-employee directors. The number of shares granted to each non-employee director is determined by dividing the value of the annual grant by the price of a share of the Company’s Class A Common Stock. New directors in any fiscal year earn a prorated amount. During fiscal 2024, there were 6,264 shares granted to non-employee directors compared to 6,640 and 5,686 during fiscal 2023 and 2022, respectively. The shares vest immediately upon grant. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. | text | 39 | monetaryItemType | text: <entity> 39 </entity> <entity type> monetaryItemType </entity type> <context> The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> The intrinsic value of SARs exercised during fiscal 2024, 2023 and 2022 was $ 39 million, $ 8 million and $ 8 million, respectively. The total fair value of SARs that vested during fiscal 2024, 2023 and 2022 was $ 1 million, $ 2 million and $ 3 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. | text | 13 | monetaryItemType | text: <entity> 13 </entity> <entity type> monetaryItemType </entity type> <context> The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid |
The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid |
The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid |
The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. | text | 59266 | sharesItemType | text: <entity> 59266 </entity> <entity type> sharesItemType </entity type> <context> The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. | text | 45460 | sharesItemType | text: <entity> 45460 </entity> <entity type> sharesItemType </entity type> <context> The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. | text | 66923 | sharesItemType | text: <entity> 66923 </entity> <entity type> sharesItemType </entity type> <context> The Company also issues cash-settled share-based compensation awards, including cash-settled restricted stock units and cash-settled performance stock units that are classified as liability awards. These awards are expensed over the vesting period of the related award, which is typically three years . Compensation cost is calculated as the fair market value of the Company’s Class A Common Stock on the grant date multiplied by the number of share-equivalents granted, net of forfeitures. The fair value for all cash-settled awards and the expected attainment of the performance goals for the cash-settled performance stock units is reviewed at the end of each reporting period, with adjustments recorded to compensation expense in the Consolidated Statements of Operations, as necessary. Cash settlement is based on the fair value of share equivalents at the time of vesting, which was $ 13 million, $ 9 million and $ 5 million in 2024, 2023 and 2022, respectively. Share-equivalents issued under these programs totaled 59,266 , 45,460 and 66,923 in fiscal 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
Eligible Zebra employees may purchase common stock at 95 % of the fair market value at the date of purchase pursuant to the Zebra Technologies Corporation 2020 Employee Stock Purchase Plan (“2020 ESPP”). Employees may make purchases by cash or payroll deductions up to certain limits. The aggregate number of shares that may be purchased under the 2020 ESPP is 1,500,000 shares. As of December 31, 2024, 1,304,693 shares remained available for future purchase. | text | 1500000 | sharesItemType | text: <entity> 1500000 </entity> <entity type> sharesItemType </entity type> <context> Eligible Zebra employees may purchase common stock at 95 % of the fair market value at the date of purchase pursuant to the Zebra Technologies Corporation 2020 Employee Stock Purchase Plan (“2020 ESPP”). Employees may make purchases by cash or payroll deductions up to certain limits. The aggregate number of shares that may be purchased under the 2020 ESPP is 1,500,000 shares. As of December 31, 2024, 1,304,693 shares remained available for future purchase. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
Eligible Zebra employees may purchase common stock at 95 % of the fair market value at the date of purchase pursuant to the Zebra Technologies Corporation 2020 Employee Stock Purchase Plan (“2020 ESPP”). Employees may make purchases by cash or payroll deductions up to certain limits. The aggregate number of shares that may be purchased under the 2020 ESPP is 1,500,000 shares. As of December 31, 2024, 1,304,693 shares remained available for future purchase. | text | 1304693 | sharesItemType | text: <entity> 1304693 </entity> <entity type> sharesItemType </entity type> <context> Eligible Zebra employees may purchase common stock at 95 % of the fair market value at the date of purchase pursuant to the Zebra Technologies Corporation 2020 Employee Stock Purchase Plan (“2020 ESPP”). Employees may make purchases by cash or payroll deductions up to certain limits. The aggregate number of shares that may be purchased under the 2020 ESPP is 1,500,000 shares. As of December 31, 2024, 1,304,693 shares remained available for future purchase. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The Company’s effective tax rates were 16.9 %, 11.4 % and 14.9 % for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 16.9 | percentItemType | text: <entity> 16.9 </entity> <entity type> percentItemType </entity type> <context> The Company’s effective tax rates were 16.9 %, 11.4 % and 14.9 % for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:EffectiveIncomeTaxRateContinuingOperations |
The Company’s effective tax rates were 16.9 %, 11.4 % and 14.9 % for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 11.4 | percentItemType | text: <entity> 11.4 </entity> <entity type> percentItemType </entity type> <context> The Company’s effective tax rates were 16.9 %, 11.4 % and 14.9 % for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:EffectiveIncomeTaxRateContinuingOperations |
The Company’s effective tax rates were 16.9 %, 11.4 % and 14.9 % for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 14.9 | percentItemType | text: <entity> 14.9 </entity> <entity type> percentItemType </entity type> <context> The Company’s effective tax rates were 16.9 %, 11.4 % and 14.9 % for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:EffectiveIncomeTaxRateContinuingOperations |
The Company’s valuation allowance consists of certain net operating loss (“NOL”) and credit carryforwards for which the Company believes it is more likely than not that a tax benefit will not be realized. With respect to all other deferred tax assets, the Company believes it is more likely than not that the results of future operations will generate sufficient taxable income to realize a tax benefit. The Company’s valuation allowance decreased by $ 18 million from 2023, primarily due to the impact of remeasuring deferred taxes resulting from a reduction in a statutory tax rate which becomes effective in 2025. | text | 18 | monetaryItemType | text: <entity> 18 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s valuation allowance consists of certain net operating loss (“NOL”) and credit carryforwards for which the Company believes it is more likely than not that a tax benefit will not be realized. With respect to all other deferred tax assets, the Company believes it is more likely than not that the results of future operations will generate sufficient taxable income to realize a tax benefit. The Company’s valuation allowance decreased by $ 18 million from 2023, primarily due to the impact of remeasuring deferred taxes resulting from a reduction in a statutory tax rate which becomes effective in 2025. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
As of December 31, 2024, the Company had approximately $ 400 million (tax effected) of “NOLs” and $ 45 million of credit carryforwards. Approximately $ 160 million of NOLs will expire beginning in 2025 through 2043, and $ 34 million of credits will expire beginning in 2025 through 2042, with the remaining amounts of NOLs and credit carryforwards having no expiration dates. | text | 400 | monetaryItemType | text: <entity> 400 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had approximately $ 400 million (tax effected) of “NOLs” and $ 45 million of credit carryforwards. Approximately $ 160 million of NOLs will expire beginning in 2025 through 2043, and $ 34 million of credits will expire beginning in 2025 through 2042, with the remaining amounts of NOLs and credit carryforwards having no expiration dates. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwards |
As of December 31, 2024, the Company had approximately $ 400 million (tax effected) of “NOLs” and $ 45 million of credit carryforwards. Approximately $ 160 million of NOLs will expire beginning in 2025 through 2043, and $ 34 million of credits will expire beginning in 2025 through 2042, with the remaining amounts of NOLs and credit carryforwards having no expiration dates. | text | 45 | monetaryItemType | text: <entity> 45 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had approximately $ 400 million (tax effected) of “NOLs” and $ 45 million of credit carryforwards. Approximately $ 160 million of NOLs will expire beginning in 2025 through 2043, and $ 34 million of credits will expire beginning in 2025 through 2042, with the remaining amounts of NOLs and credit carryforwards having no expiration dates. </context> | us-gaap:DeferredTaxAssetsTaxCreditCarryforwards |
As of December 31, 2024, the Company had approximately $ 400 million (tax effected) of “NOLs” and $ 45 million of credit carryforwards. Approximately $ 160 million of NOLs will expire beginning in 2025 through 2043, and $ 34 million of credits will expire beginning in 2025 through 2042, with the remaining amounts of NOLs and credit carryforwards having no expiration dates. | text | 160 | monetaryItemType | text: <entity> 160 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had approximately $ 400 million (tax effected) of “NOLs” and $ 45 million of credit carryforwards. Approximately $ 160 million of NOLs will expire beginning in 2025 through 2043, and $ 34 million of credits will expire beginning in 2025 through 2042, with the remaining amounts of NOLs and credit carryforwards having no expiration dates. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration |
As of December 31, 2024, the Company had approximately $ 400 million (tax effected) of “NOLs” and $ 45 million of credit carryforwards. Approximately $ 160 million of NOLs will expire beginning in 2025 through 2043, and $ 34 million of credits will expire beginning in 2025 through 2042, with the remaining amounts of NOLs and credit carryforwards having no expiration dates. | text | 34 | monetaryItemType | text: <entity> 34 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had approximately $ 400 million (tax effected) of “NOLs” and $ 45 million of credit carryforwards. Approximately $ 160 million of NOLs will expire beginning in 2025 through 2043, and $ 34 million of credits will expire beginning in 2025 through 2042, with the remaining amounts of NOLs and credit carryforwards having no expiration dates. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration |
As of December 31, 2024 and December 31, 2023, there were $ 13 million and $ 9 million of unrecognized tax benefits that, if recognized, would affect the annual effective tax rate. Additionally, fiscal years 2009 through 2024 remain open to examination by multiple foreign and U.S. state taxing jurisdictions. | text | 13 | monetaryItemType | text: <entity> 13 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and December 31, 2023, there were $ 13 million and $ 9 million of unrecognized tax benefits that, if recognized, would affect the annual effective tax rate. Additionally, fiscal years 2009 through 2024 remain open to examination by multiple foreign and U.S. state taxing jurisdictions. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
As of December 31, 2024 and December 31, 2023, there were $ 13 million and $ 9 million of unrecognized tax benefits that, if recognized, would affect the annual effective tax rate. Additionally, fiscal years 2009 through 2024 remain open to examination by multiple foreign and U.S. state taxing jurisdictions. | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and December 31, 2023, there were $ 13 million and $ 9 million of unrecognized tax benefits that, if recognized, would affect the annual effective tax rate. Additionally, fiscal years 2009 through 2024 remain open to examination by multiple foreign and U.S. state taxing jurisdictions. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
Anti-dilutive share-based compensation awards are excluded from diluted earnings per share calculations. There were 46,278 , 129,856 and 173,519 shares that were anti-dilutive for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 46278 | sharesItemType | text: <entity> 46278 </entity> <entity type> sharesItemType </entity type> <context> Anti-dilutive share-based compensation awards are excluded from diluted earnings per share calculations. There were 46,278 , 129,856 and 173,519 shares that were anti-dilutive for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Anti-dilutive share-based compensation awards are excluded from diluted earnings per share calculations. There were 46,278 , 129,856 and 173,519 shares that were anti-dilutive for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 129856 | sharesItemType | text: <entity> 129856 </entity> <entity type> sharesItemType </entity type> <context> Anti-dilutive share-based compensation awards are excluded from diluted earnings per share calculations. There were 46,278 , 129,856 and 173,519 shares that were anti-dilutive for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Anti-dilutive share-based compensation awards are excluded from diluted earnings per share calculations. There were 46,278 , 129,856 and 173,519 shares that were anti-dilutive for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 173519 | sharesItemType | text: <entity> 173519 </entity> <entity type> sharesItemType </entity type> <context> Anti-dilutive share-based compensation awards are excluded from diluted earnings per share calculations. There were 46,278 , 129,856 and 173,519 shares that were anti-dilutive for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
During the years ended December 31, 2024, 2023 and 2022, the Company received cash proceeds of $ 1,019 million, $ 1,404 million and $ 1,496 million, respectively, from the sales of accounts receivables under its factoring arrangements. As of December 31, 2024 and 2023, there were a total of $ 28 million and $ 56 million, respectively, of uncollected receivables that had been sold and removed from the Company’s Consolidated Balance Sheets. | text | 1019 | monetaryItemType | text: <entity> 1019 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company received cash proceeds of $ 1,019 million, $ 1,404 million and $ 1,496 million, respectively, from the sales of accounts receivables under its factoring arrangements. As of December 31, 2024 and 2023, there were a total of $ 28 million and $ 56 million, respectively, of uncollected receivables that had been sold and removed from the Company’s Consolidated Balance Sheets. </context> | us-gaap:ProceedsFromSaleAndCollectionOfReceivables |
During the years ended December 31, 2024, 2023 and 2022, the Company received cash proceeds of $ 1,019 million, $ 1,404 million and $ 1,496 million, respectively, from the sales of accounts receivables under its factoring arrangements. As of December 31, 2024 and 2023, there were a total of $ 28 million and $ 56 million, respectively, of uncollected receivables that had been sold and removed from the Company’s Consolidated Balance Sheets. | text | 1404 | monetaryItemType | text: <entity> 1404 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company received cash proceeds of $ 1,019 million, $ 1,404 million and $ 1,496 million, respectively, from the sales of accounts receivables under its factoring arrangements. As of December 31, 2024 and 2023, there were a total of $ 28 million and $ 56 million, respectively, of uncollected receivables that had been sold and removed from the Company’s Consolidated Balance Sheets. </context> | us-gaap:ProceedsFromSaleAndCollectionOfReceivables |
During the years ended December 31, 2024, 2023 and 2022, the Company received cash proceeds of $ 1,019 million, $ 1,404 million and $ 1,496 million, respectively, from the sales of accounts receivables under its factoring arrangements. As of December 31, 2024 and 2023, there were a total of $ 28 million and $ 56 million, respectively, of uncollected receivables that had been sold and removed from the Company’s Consolidated Balance Sheets. | text | 1496 | monetaryItemType | text: <entity> 1496 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company received cash proceeds of $ 1,019 million, $ 1,404 million and $ 1,496 million, respectively, from the sales of accounts receivables under its factoring arrangements. As of December 31, 2024 and 2023, there were a total of $ 28 million and $ 56 million, respectively, of uncollected receivables that had been sold and removed from the Company’s Consolidated Balance Sheets. </context> | us-gaap:ProceedsFromSaleAndCollectionOfReceivables |
Fees incurred in connection with these arrangements are included within Other expense, net on the Consolidated Statements of Operations and were $ 9 million, $ 11 million and $ 5 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> Fees incurred in connection with these arrangements are included within Other expense, net on the Consolidated Statements of Operations and were $ 9 million, $ 11 million and $ 5 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:CashFlowsBetweenTransfereeAndTransferorServicingFees |
Fees incurred in connection with these arrangements are included within Other expense, net on the Consolidated Statements of Operations and were $ 9 million, $ 11 million and $ 5 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> Fees incurred in connection with these arrangements are included within Other expense, net on the Consolidated Statements of Operations and were $ 9 million, $ 11 million and $ 5 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:CashFlowsBetweenTransfereeAndTransferorServicingFees |
Fees incurred in connection with these arrangements are included within Other expense, net on the Consolidated Statements of Operations and were $ 9 million, $ 11 million and $ 5 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> Fees incurred in connection with these arrangements are included within Other expense, net on the Consolidated Statements of Operations and were $ 9 million, $ 11 million and $ 5 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:CashFlowsBetweenTransfereeAndTransferorServicingFees |
Our operations consist of two reportable segments that provide complementary offerings to our customers: Asset Intelligence & Tracking (“AIT”), which includes barcode and card printing, RFID and RTLS offerings, supplies, and services; and Enterprise Visibility & Mobility (“EVM”), which includes mobile computing, data capture, fixed industrial scanning and machine vision, services, and workflow optimization solutions. The reportable segments have been identified based on the financial data utilized by the Company’s Chief Executive Officer (the chief operating decision maker or “CODM”) to assess segment performance and allocate resources among the Company’s segments. The CODM reviews adjusted operating income to assess segment profitability primarily during the Company’s annual budget and forecasting process. The CODM assesses the profitability of each segment relative to its long-term growth objectives in evaluating resource allocation priorities. Segment assets are not reviewed by the Company’s CODM and therefore are not disclosed below. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> Our operations consist of two reportable segments that provide complementary offerings to our customers: Asset Intelligence & Tracking (“AIT”), which includes barcode and card printing, RFID and RTLS offerings, supplies, and services; and Enterprise Visibility & Mobility (“EVM”), which includes mobile computing, data capture, fixed industrial scanning and machine vision, services, and workflow optimization solutions. The reportable segments have been identified based on the financial data utilized by the Company’s Chief Executive Officer (the chief operating decision maker or “CODM”) to assess segment performance and allocate resources among the Company’s segments. The CODM reviews adjusted operating income to assess segment profitability primarily during the Company’s annual budget and forecasting process. The CODM assesses the profitability of each segment relative to its long-term growth objectives in evaluating resource allocation priorities. Segment assets are not reviewed by the Company’s CODM and therefore are not disclosed below. </context> | us-gaap:NumberOfReportableSegments |
These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. | text | 24 | percentItemType | text: <entity> 24 </entity> <entity type> percentItemType </entity type> <context> These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. | text | 13 | percentItemType | text: <entity> 13 </entity> <entity type> percentItemType </entity type> <context> These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. | text | 22 | percentItemType | text: <entity> 22 </entity> <entity type> percentItemType </entity type> <context> These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. | text | 17 | percentItemType | text: <entity> 17 </entity> <entity type> percentItemType </entity type> <context> These customers accounted for 24 %, 13 % and 11 %, respectively, of accounts receivable as of December 31, 2024, and 22 %, 10 % and 17 %, respectively, of accounts receivable as of December 31, 2023. No other customer accounted for more than 10% of total Net sales during the years ended December 31, 2024, 2023 or 2022, or more than 10% of outstanding accounts receivable as of December 31, 2024 or 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.